Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12O3 |
Molecular Weight | 228.2433 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1=CC=C(C=C1)C(=O)OCC2=CC=CC=C2
InChI
InChIKey=MOZDKDIOPSPTBH-UHFFFAOYSA-N
InChI=1S/C14H12O3/c15-13-8-6-12(7-9-13)14(16)17-10-11-4-2-1-3-5-11/h1-9,15H,10H2
Molecular Formula | C14H12O3 |
Molecular Weight | 228.2433 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL206 Sources: https://www.ncbi.nlm.nih.gov/pubmed/23220609 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
PubMed
Title | Date | PubMed |
---|---|---|
Oestrogenic activity of benzylparaben. | 2003 Jan-Feb |
|
Optimization by experimental design and artificial neural networks of the ion-interaction reversed-phase liquid chromatographic separation of twenty cosmetic preservatives. | 2004 Mar 12 |
|
A review of the endocrine activity of parabens and implications for potential risks to human health. | 2005 Jun |
|
Determination of parabens in pharmaceutical formulations by solid-phase microextraction-ion mobility spectrometry. | 2005 Sep 15 |
|
Optimisation of a solid-phase microextraction method for the determination of parabens in water samples at the low ng per litre level. | 2006 Aug 18 |
|
Parabens as urinary biomarkers of exposure in humans. | 2006 Dec |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Preliminary ecological risk assessment of butylparaben and benzylparaben -2. Fate and partitioning in aquatic environments. | 2007 |
|
Preliminary ecological risk assessment of butylparaben and benzylparaben -1. Removal efficiency in wastewater treatment, acute/chronic toxicity for aquatic organisms, and effects on medaka gene expression. | 2007 |
|
Hydrolysis of a series of parabens by skin microsomes and cytosol from human and minipigs and in whole skin in short-term culture. | 2007 Dec 1 |
|
Inter-individual variability in esterases in human liver. | 2007 Sep 15 |
|
Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products. | 2008 |
|
Probabilistic ecological hazard assessment of parabens using Daphnia magna and Pimephales promelas. | 2009 Dec |
|
Parabens in male infertility-is there a mitochondrial connection? | 2009 Jan |
|
Evaluation of estrogenic activity of parabens and their chlorinated derivatives by using the yeast two-hybrid assay and the enzyme-linked immunosorbent assay. | 2009 Jan |
|
Ultra-high-performance liquid chromatography-tandem mass spectrometry for determining the presence of eleven personal care products in surface and wastewaters. | 2009 Oct 16 |
|
Metabolism of parabens (4-hydroxybenzoic acid esters) by hepatic esterases and UDP-glucuronosyltransferases in man. | 2010 |
|
In-sample acetylation-non-porous membrane-assisted liquid-liquid extraction for the determination of parabens and triclosan in water samples. | 2010 Jul |
|
Self-reported chemicals exposure, beliefs about disease causation, and risk of breast cancer in the Cape Cod Breast Cancer and Environment Study: a case-control study. | 2010 Jul 20 |
|
Molecularly imprinted polymer for the extraction of parabens from environmental solid samples prior to their determination by high performance liquid chromatography-ultraviolet detection. | 2010 Mar 15 |
|
Urinary concentrations of four parabens in the U.S. population: NHANES 2005-2006. | 2010 May |
|
Occurrence and sources of selected phenolic endocrine disruptors in Ria de Aveiro, Portugal. | 2010 May |
|
Simultaneous quantitation of parabens, triclosan, and methyl triclosan in indoor house dust using solid phase extraction and gas chromatography-mass spectrometry. | 2010 Oct 6 |
|
Removal of parabens from aqueous solution using β-cyclodextrin cross-linked polymer. | 2010 Sep 20 |
|
Rat α-Fetoprotein binding affinities of a large set of structurally diverse chemicals elucidated the relationships between structures and binding affinities. | 2012 Nov 19 |
|
Effects of parabens on adipocyte differentiation. | 2013 Jan |
|
Comparative study on transcriptional activity of 17 parabens mediated by estrogen receptor α and β and androgen receptor. | 2013 Jul |
|
Inverse antagonist activities of parabens on human oestrogen-related receptor γ (ERRγ): in vitro and in silico studies. | 2013 Jul 1 |
|
The estrogenic effects of benzylparaben at low doses based on uterotrophic assay in immature SD rats. | 2013 Mar |
|
Human sex hormone-binding globulin binding affinities of 125 structurally diverse chemicals and comparison with their binding to androgen receptor, estrogen receptor, and α-fetoprotein. | 2015 Feb |
Patents
Sample Use Guides
in mice (topical): of three daily doses of 33 mg to dorsal skin
in rats (intragastric): 0.16 mg/kg body up to 100 μg/kg body weight
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/12518336
Benzylparaben was able to displace [(3)H]oestradiol from cytosolic oestrogen receptor (ER) of MCF7 human breast cancer cells by 22% at 1000-fold molar excess, by 40% at 10,000-fold molar excess, by 57% at 100 000-fold molar excess and by 100% at 1,000,000-fold molar excess. It was able to increase expression of a stably transfected oestrogen responsive reporter gene (ERE-CAT) in MCF7 cells after 24 h at 10(-5)M/10(-4)M and after 7 days at 10(-6)M/10(-5)M/10(-4)M. Proliferation of MCF7 cells could be increased by 10(-6)M/10(-5)M benzylparaben and this could be inhibited by 10(-7)M pure anti-oestrogen ICI 182,780, indicating that growth effects were ER mediated
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:51:28 GMT 2023
by
admin
on
Fri Dec 15 15:51:28 GMT 2023
|
Record UNII |
8Y41DYV4VG
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
||
|
NCI_THESAURUS |
C92608
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C95327
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
8080
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
N0000184306
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
SUB13025MIG
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
8Y41DYV4VG
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
SUB61024
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
C057775
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
202-311-9
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
BENZYLPARABEN
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | Description: A white to creamy white, crystalline powder; odourless or almost odourless. Solubility: Practically insoluble in water; soluble in ethanol (~750 g/l) TS and ether R; dissolves in solutions of alkali hydroxides. Category: Antimicrobial preservative. Storage: Benzyl hydroxybenzoate should be kept in a well-closed container. Requirement: Benzyl hydroxybenzoate contains not less than 99.0% and not more than the equivalent of 101.0% of C14H12O3. | ||
|
7180
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
DB14176
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
94-18-8
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
DTXSID9022526
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
8Y41DYV4VG
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
100000134265
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | |||
|
19075
Created by
admin on Fri Dec 15 15:51:28 GMT 2023 , Edited by admin on Fri Dec 15 15:51:28 GMT 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
http://apps.who.int/phint/pdf/b/Jb.6.1.52.pdf
|